Albany Molecular Research Inc. (AMRI) Selects FirstLight Fiber for 10 Gbps Network Upgrade

ALBANY, NY--(Marketwired - Feb 27, 2014) -  FirstLight Fiber, a facilities-based telecommunications service provider operating fiber optic networks in Upstate New York and Northern New England with connectivity to Canada, announced today that Albany Molecular Research Inc. (NASDAQ: AMRI) has chosen FirstLight to upgrade its network.

As a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services, AMRI operates a vast data network connecting multiple locations. To date, FirstLight provides network services to numerous AMRI locations. In an effort to meet its ever-increasing data needs, AMRI looked to FirstLight to upgrade its Ethernet-based services, as part of a continuous effort to enhance the bandwidth and reliability of its data network.

"Because of its responsiveness and adaptability to our needs, FirstLight has been a trusted partner to AMRI for more than a decade," commented Alan Tosi, IT Infrastructure Manager for AMRI. "With FirstLight's help, we were able to once again enhance our network's capacity and reliability. All of our needs were met quickly and completely by the FirstLight team; making this upgrade seamless."

"As one of our longest standing customers, our relationship with AMRI is an example of FirstLight's ability to continually meet our customers' requirements as their data-network needs expand," stated Kurt Van Wagenen, President and CEO of FirstLight. "Our key focus is to ensure that we have the high-quality services and scalable bandwidth our clients need to succeed in this digital age."

"The fiber-based network that FirstLight provides affords us the flexibility we need to continually evolve our infrastructure knowing that it will support important technology changes in the future," added Tosi. "We look forward to continuing to work with FirstLight."

To address the data intensive network needs of companies in the pharmaceutical industry, FirstLight provides a comprehensive portfolio of fiber-based secure, scalable, high reliability telecommunications solutions backed by a knowledgeable staff to support advanced applications for multi-site companies.

To learn more about FirstLight, visit www.firstlight.net, or follow the Company on Twitter and LinkedIn.

About FirstLight Fiber

FirstLight Fiber, headquartered in Albany, NY, provides fiber optic data, Internet, colocation and voice services to enterprise and carrier customers in Upstate New York and Northern New England with connectivity to Canada utilizing its own fiber optic network, which spans over 190,000 fiber miles connecting in excess of 1,400 lit locations. FirstLight offers a robust suite of advanced telecommunications products, including dedicated Internet access, Metro Ethernet, traditional TDM solutions, SIP trunks, virtual PBX and audio-conferencing, managed commercial wireless systems, and Data Center Colocation. FirstLight's clientele includes national cellular providers and CLECs and many leading enterprises, spanning high tech manufacturing and research, hospitals and healthcare, banking and financial, secondary education, colleges and universities, and local and state governments. FirstLight is a portfolio company of Boston-based private equity firm Riverside Partners.

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).